Bronconex Acticap

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Toimeaine:

Mometasone furoate 400ug (anhydrous)

Saadav alates:

Organon (New Zealand) Limited

INN (Rahvusvaheline Nimetus):

Mometasone furoate 400 µg (anhydrous)

Annus:

400 mcg/dose

Ravimvorm:

Powder for inhalation

Koostis:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

Ühikuid pakis:

Inhaler, metered, DPI, (sample), 14 dose units

Klass:

Prescription

Retsepti tüüp:

Prescription

Valmistatud:

MSD International GmbH (Singapore Branch)

Näidustused:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Toote kokkuvõte:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

Loa andmise kuupäev:

2000-12-05